Rep. Tim Moore Buys Intel Corporation (NASDAQ:INTC) Shares

Key Points

• Representative Tim Moore purchased shares of Intel Corporation (NASDAQ:INTC), investing between $15,001 and $50,000 on August 11th, as disclosed in a filing on September 3rd.
• Intel's shares are currently trading at approximately $24.61, showing an upward movement of 2.5%, with a market capitalization of $107.72 billion.
• In its most recent earnings report, Intel missed analysts' EPS consensus estimates and reported a revenue of $12.86 billion, slightly exceeding projections.

Representative Tim Moore (R-North Carolina) recently bought shares of Intel Corporation NASDAQ: INTC. In a filing disclosed on September 03rd, the Representative disclosed that they had bought between $15,001 and $50,000 in Intel stock on August 11th.

Representative Tim Moore also recently made the following trade(s):

• Sold $100,001 - $250,000 in shares of Centene NYSE: CNC on 8/18/2025.
• Sold $50,001 - $100,000 in shares of UnitedHealth Group NYSE: UNH on 8/15/2025.
• Sold $100,001 - $250,000 in shares of Intel NASDAQ: INTC on 8/13/2025.
• Sold $50,001 - $100,000 in shares of Hyster-Yale NYSE: HY on 8/13/2025.
• Purchased $15,001 - $50,000 in shares of Hyster-Yale NYSE: HY on 8/12/2025.
• Purchased $15,001 - $50,000 in shares of UnitedHealth Group NYSE: UNH on 8/8/2025.
• Purchased $1,001 - $15,000 in shares of Centene NYSE: CNC on 8/8/2025.
• Purchased $15,001 - $50,000 in shares of Intel NASDAQ: INTC on 8/8/2025.
• Purchased $15,001 - $50,000 in shares of Hyster-Yale NYSE: HY on 8/7/2025.
• Purchased $15,001 - $50,000 in shares of Centene NYSE: CNC on 8/7/2025.

Intel Trading Up 2.5%

Shares of NASDAQ:INTC opened at $24.61 on Friday. Intel Corporation has a 1 year low of $17.67 and a 1 year high of $27.55. The firm has a market capitalization of $107.72 billion, a price-to-earnings ratio of -5.16 and a beta of 1.23. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.24 and a quick ratio of 0.92. The business's 50 day moving average price is $22.67 and its 200-day moving average price is $21.89.

Intel (NASDAQ:INTC - Get Free Report) last announced its earnings results on Thursday, July 24th. The chip maker reported ($0.10) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.01 by ($0.11). The business had revenue of $12.86 billion for the quarter, compared to analysts' expectations of $11.88 billion. Intel had a negative net margin of 38.64% and a negative return on equity of 3.78%. The company's quarterly revenue was up .5% on a year-over-year basis. During the same quarter last year, the business earned $0.02 EPS. Intel has set its Q3 2025 guidance at 0.000-0.000 EPS. On average, equities research analysts forecast that Intel Corporation will post -0.11 earnings per share for the current fiscal year.

Institutional Trading of Intel

Several large investors have recently bought and sold shares of INTC. N.E.W. Advisory Services LLC acquired a new stake in Intel in the first quarter valued at $25,000. HFM Investment Advisors LLC purchased a new position in Intel during the first quarter worth about $25,000. Vermillion Wealth Management Inc. purchased a new position in Intel during the fourth quarter worth about $27,000. MJT & Associates Financial Advisory Group Inc. purchased a new position in shares of Intel in the 1st quarter worth about $27,000. Finally, West Branch Capital LLC purchased a new position in shares of Intel in the 2nd quarter worth about $28,000. Institutional investors and hedge funds own 64.53% of the company's stock.

Analyst Upgrades and Downgrades

INTC has been the topic of several analyst reports. Mizuho lifted their price target on Intel from $22.00 to $23.00 and gave the stock a "neutral" rating in a report on Thursday, July 3rd. Needham & Company LLC reaffirmed a "hold" rating on shares of Intel in a research report on Friday, July 25th. Loop Capital started coverage on shares of Intel in a research note on Monday, July 21st. They issued a "hold" rating and a $25.00 price target for the company. Citigroup reiterated a "hold" rating on shares of Intel in a report on Tuesday, July 8th. Finally, Deutsche Bank Aktiengesellschaft started coverage on Intel in a research note on Wednesday, May 21st. They set a "hold" rating and a $23.00 target price for the company. One investment analyst has rated the stock with a Buy rating, twenty-two have assigned a Hold rating and five have issued a Sell rating to the stock. Based on data from MarketBeat.com, Intel currently has a consensus rating of "Reduce" and a consensus price target of $22.17.

About Representative Moore

Timothy K. Moore (Republican Party) is a member of the U.S. House, representing North Carolina's 14th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027. Moore (Republican Party) ran for election to the U.S. House to represent North Carolina's 14th Congressional District. He won in the general election on November 5, 2024. Moore served as speaker of the House from 2015 to 2025. Timothy Moore earned his B.A. from the University of North Carolina-Chapel Hill in 1992 and his J.D. from the Oklahoma City University School of Law in 1995. His professional experience includes working as an attorney.

About Intel

Intel Corporation designs, develops, manufactures, markets, and sells computing and related products and services worldwide. It operates through Client Computing Group, Data Center and AI, Network and Edge, Mobileye, and Intel Foundry Services segments. The company's products portfolio comprises central processing units and chipsets, system-on-chips (SoCs), and multichip packages; mobile and desktop processors; hardware products comprising graphics processing units (GPUs), domain-specific accelerators, and field programmable gate arrays (FPGAs); and memory and storage, connectivity and networking, and other semiconductor products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.